title: Acidosis drives damage-associated molecular pattern (DAMP)-induced interleukin-1 secretion via a caspase-1-independent pathway.
abstract: The proinflammatory cytokine IL-1β is a key mediator of inflammatory responses that contribute to and exacerbate brain injury. IL-1β is synthesized by microglia in the brain as an inactive precursor (pro-IL-1β). Cleavage of pro-IL-1β to a mature form is stimulated by damage-associated molecular patterns (DAMPs). These DAMPs are sensed by a pattern recognition receptor called NLRP3, which forms an inflammasome, resulting in the activation of caspase-1 and cleavage of pro-IL-1β. To date, regulation of the inflammasome in culture has been studied under normal culture conditions, and it is not known how DAMPs signal under disease relevant conditions such as acidosis. Given the presence of acidosis in pathological states, our objective was to test the hypothesis that acidic conditions modify DAMP-induced IL-1β release from cultured primary mouse glial cells. When LPS-primed glial cells were stimulated with DAMPs under acidic conditions (pH 6.2), the predominant IL-1β form secreted was the 20-kDa rather than the 17-kDa caspase-1-dependent species. Lactic acidosis, induced by the addition of 25 mm lactic acid, also induced the release of 20-kDa IL-1β. This 20-kDa product was produced independently of NLRP3 and caspase-1 but was inhibited by the cathepsin D inhibitor pepstatin A. These data suggest that under disease relevant acidosis, DAMPs and lactic acid induce the secretion of IL-1β independently of the inflammasome. Therapeutic strategies directed to the inhibition of IL-1β processing should therefore consider alternative processing of IL-1β in addition to caspase-1-dependent processing.
authors.affiliation: From the Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom.
authors.forename: Michelle E
authors.initials: ME
authors.lastname: Edye
authors.affiliation: From the Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom.
authors.forename: Gloria
authors.initials: G
authors.lastname: Lopez-Castejon
authors.affiliation: From the Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom. Electronic address: stuart.allan@manchester.ac.uk.
authors.forename: Stuart M
authors.initials: SM
authors.lastname: Allan
authors.affiliation: From the Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom.
authors.forename: David
authors.initials: D
authors.lastname: Brough
mesh_terms: D000140:Acidosis, Lactic / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism; D020170:Caspase 1 / Q000235:genetics / Q000378:metabolism*; D002402:Cathepsin D / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D006801:Humans; D006863:Hydrogen-Ion Concentration; D058847:Inflammasomes / Q000235:genetics / Q000378:metabolism*; D053583:Interleukin-1beta / Q000235:genetics / Q000378:metabolism*; D019344:Lactic Acid / Q000009:adverse effects / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000633:toxicity; D051379:Mice; D018345:Mice, Knockout; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; D009457:Neuroglia / Q000378:metabolism* / Q000473:pathology; D010436:Pepstatins / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology; D015398:Signal Transduction
chemical_list: D002352:Carrier Proteins; C508585:IL1B protein, human; D058847:Inflammasomes; D053583:Interleukin-1beta; D008070:Lipopolysaccharides; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human; C492716:Nlrp3 protein, mouse; D010436:Pepstatins; D011480:Protease Inhibitors; D019344:Lactic Acid; D020170:Caspase 1; C533922:CTSD protein, human; D002402:Cathepsin D; C533923:Ctsd protein, mouse; C031375:pepstatin
keywords: Acidosis; Caspase; Glia; Inflammation; Innate Immunity; Interleukin; Stroke
references.citation: Science. 2012 Sep 21;337(6101):1456-7
references.pmid: 22997310
references.citation: Mol Cell. 2011 Oct 21;44(2):265-78
references.pmid: 22017873
references.citation: Arthritis Rheum. 2009 Dec;60(12):3524-30
references.pmid: 19950297
references.citation: Stroke. 1981 Jan-Feb;12(1):77-82
references.pmid: 6784285
references.citation: J Neuroinflammation. 2011 Dec 29;8:186
references.pmid: 22206506
references.citation: Immunity. 2012 Mar 23;36(3):388-400
references.pmid: 22444631
references.citation: Science. 2011 Jul 29;333(6042):558-9
references.pmid: 21798933
references.citation: Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20388-93
references.pmid: 19918053
references.citation: Nat Rev Immunol. 2005 Aug;5(8):629-40
references.pmid: 16034365
references.citation: J Neurochem. 2011 May;117(4):712-23
references.pmid: 21395581
references.citation: Nature. 2012 Jan 18;481(7381):278-86
references.pmid: 22258606
references.citation: J Neurosci. 2001 Aug 1;21(15):5528-34
references.pmid: 11466424
references.citation: Nature. 2006 Mar 9;440(7081):237-41
references.pmid: 16407889
references.citation: Cell. 2010 Mar 19;140(6):821-32
references.pmid: 20303873
references.citation: J Intern Med. 2011 Jan;269(1):16-28
references.pmid: 21158974
references.citation: Dis Model Mech. 2012 Nov;5(6):823-33
references.pmid: 22679224
references.citation: J Biol Chem. 2013 May 10;288(19):13410-9
references.pmid: 23530046
references.citation: J Immunol. 2002 May 15;168(10):5310-7
references.pmid: 11994489
references.citation: Nature. 2006 Mar 9;440(7081):228-32
references.pmid: 16407890
references.citation: Cell. 2004 Sep 17;118(6):687-98
references.pmid: 15369669
references.citation: Annu Rev Immunol. 2010;28:321-42
references.pmid: 20307211
references.citation: Front Immunol. 2012 Sep 18;3:288
references.pmid: 23024646
references.citation: J Cereb Blood Flow Metab. 2011 Aug;31(8):1743-50
references.pmid: 21386856
references.citation: Arthritis Rheum. 2009 Dec;60(12):3651-62
references.pmid: 19950280
references.citation: Immunity. 2013 Feb 21;38(2):285-95
references.pmid: 23395675
references.citation: Nat Rev Immunol. 2010 Dec;10(12):826-37
references.pmid: 21088683
references.citation: Cell. 2010 Mar 19;140(6):935-50
references.pmid: 20303881
references.citation: Br J Pharmacol. 2009 Aug;157(8):1318-29
references.pmid: 19681864
references.citation: J Immunol. 1997 Feb 15;158(4):1818-24
references.pmid: 9029121
references.citation: J Biol Chem. 1991 Apr 15;266(11):7081-6
references.pmid: 2016316
references.citation: Arthritis Rheum. 1989 Nov;32(11):1443-52
references.pmid: 2554932
references.citation: Neuron. 2005 Nov 23;48(4):635-46
references.pmid: 16301179
references.citation: J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1366-72
references.pmid: 16170078